PURPOSE: More than 130 years ago, circulating tumour cells (CTCs) and disseminated tumour cells (DTCs) have been linked to metastasis. Since then, a myriad of studies attempted to characterise and elucidate the clinical impact of CTCs/DTCs, amongst others in colorectal cancer (CRC). Due to a flood of heterogeneous findings regarding CTCs/DTCs in CRC, this review aims to describe the known facts about CTC/DTC biology and clinical impact. METHODS: To identify the basic scientific literature regarding the biology and clinical impact of CTCs/DTCs in CRC, we reviewed the literature in the PubMed database. We focused on publications written in English and published until January 2012. As search terms, we used "colorectal cancer (CRC)", "colon cancer (CC)", "CTC", "DTC", "bone marrow (BM)", "lymph node (LN)", "peripheral blood (PB)", "significance" and "prognosis". RESULTS: CTC detection and quantification under standardised conditions is feasible. Several studies in large patient settings have revealed prognostic impact of CTCs in CRC. CRC-derived DTC detection and analysis in BM exhibits a more heterogeneous picture but also shows clinical value. Furthermore, the presence of DTCs in LN has a strong prognostic impact in CRC. CONCLUSIONS: Clinical relevance and prognostic significance of CTCs/DTCs in CRC have been clearly demonstrated in many experimental studies. The major challenge in CTC/DTC research is now to harmonise the various identification and detection approaches and consequently to conduct large prospective multi-institutional trials to verify the use of CTCs/DTCs as a valid prognostic and predictive biomarker for clinical routine.
PURPOSE: More than 130 years ago, circulating tumour cells (CTCs) and disseminated tumour cells (DTCs) have been linked to metastasis. Since then, a myriad of studies attempted to characterise and elucidate the clinical impact of CTCs/DTCs, amongst others in colorectal cancer (CRC). Due to a flood of heterogeneous findings regarding CTCs/DTCs in CRC, this review aims to describe the known facts about CTC/DTC biology and clinical impact. METHODS: To identify the basic scientific literature regarding the biology and clinical impact of CTCs/DTCs in CRC, we reviewed the literature in the PubMed database. We focused on publications written in English and published until January 2012. As search terms, we used "colorectal cancer (CRC)", "colon cancer (CC)", "CTC", "DTC", "bone marrow (BM)", "lymph node (LN)", "peripheral blood (PB)", "significance" and "prognosis". RESULTS: CTC detection and quantification under standardised conditions is feasible. Several studies in large patient settings have revealed prognostic impact of CTCs in CRC. CRC-derived DTC detection and analysis in BM exhibits a more heterogeneous picture but also shows clinical value. Furthermore, the presence of DTCs in LN has a strong prognostic impact in CRC. CONCLUSIONS: Clinical relevance and prognostic significance of CTCs/DTCs in CRC have been clearly demonstrated in many experimental studies. The major challenge in CTC/DTC research is now to harmonise the various identification and detection approaches and consequently to conduct large prospective multi-institutional trials to verify the use of CTCs/DTCs as a valid prognostic and predictive biomarker for clinical routine.
Authors: R Broll; K Lembcke; C Stock; M Zingler; M Duchrow; H Schimmelpenning; M Strik; G Muller; P Kujath; H P Bruch Journal: Langenbecks Arch Chir Date: 1996
Authors: F Jeroen Vogelaar; Wilma E Mesker; Arjen M Rijken; Gaby W van Pelt; Antonia M van Leeuwen; Hans J Tanke; Rob A Tollenaar; Gerrit J Liefers Journal: BMC Cancer Date: 2010-04-20 Impact factor: 4.430
Authors: Kazuo Koyanagi; Anton J Bilchik; Sukamal Saha; Roderick R Turner; David Wiese; Martin McCarter; Perry Shen; Linda Deacon; David Elashoff; Dave S B Hoon Journal: Clin Cancer Res Date: 2008-11-15 Impact factor: 12.531
Authors: Eric Camerer; Aisha A Qazi; Daniel N Duong; Ivo Cornelissen; Rommel Advincula; Shaun R Coughlin Journal: Blood Date: 2004-03-18 Impact factor: 22.113
Authors: Christoph Ausch; Veronika Buxhofer-Ausch; Ulrike Olszewski; Rudolf Schiessel; Emil Ogris; Wolfgang Hinterberger; Gerhard Hamilton Journal: J Gastrointest Surg Date: 2009-09-02 Impact factor: 3.452
Authors: S C C Wong; S S M Ng; M T Cheung; L Y Luk; C M L Chan; A H K Cheung; V H M Lee; P B S Lai; B B Y Ma; E P Hui; M Y Y Lam; T C C Au; A T C Chan Journal: Br J Cancer Date: 2011-03-01 Impact factor: 7.640
Authors: Alexander M Betzler; Susan Kochall; Linda Blickensdörfer; Sebastian A Garcia; May-Linn Thepkaysone; Lahiri K Nanduri; Michael H Muders; Jürgen Weitz; Christoph Reissfelder; Sebastian Schölch Journal: J Vis Exp Date: 2017-07-06 Impact factor: 1.355
Authors: Aleksander Skardal; Mahesh Devarasetty; Christopher Rodman; Anthony Atala; Shay Soker Journal: Ann Biomed Eng Date: 2015-03-17 Impact factor: 3.934
Authors: Ulrich Bork; Robert Grützmann; Nuh N Rahbari; Sebastian Schölch; Marius Distler; Christoph Reissfelder; Moritz Koch; Jürgen Weitz Journal: World J Gastroenterol Date: 2014-08-14 Impact factor: 5.742
Authors: Susan Kochall; May-Linn Thepkaysone; Sebastián A García; Alexander M Betzler; Jürgen Weitz; Christoph Reissfelder; Sebastian Schölch Journal: J Vis Exp Date: 2017-07-18 Impact factor: 1.355